We support early-stage biotech and longevity-focused founders that are changing the world. We help these companies gain industrial momentum, raise capital, and shape the future of biotech. Our approach is based on growing the whole ecosystem. We fund companies in complementary industrial sectors, empowering us to build a broad community of biotech innovators that can exchange their expertise and build on each other's successes.
Location: Switzerland
Employees: 1-10
Founded date: 2020
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Mentions in press and media 10
| Date | Title | Description |
| 03.12.2024 | Latvian LongeVC invests in US startup Glyphic Biotechnologies | Latvian fund LongeVC has invested in US-based Glyphic Biotechnologies , which is developing a protein sequencing platform. Founded in New York in 2021 by Daniel Estandian and Joshua Yang, Glyphic Biotechnologies is developing a protein sequ... |
| 14.12.2023 | Когда мы будем жить до 150 лет? | Спойлер: нескоро Жить долго и счастливо — понятное желание. Ответ на вопрос, что такое счастье и где его искать, каждому человеку приходится искать самостоятельно. А вот о секретах долголетия нам могут рассказать ученые. Например, продлить ... |
| 15.11.2023 | Generative AI skincare company Haut.AI raises €2 Million | The Estonian company's product includes SkinGPT, a generative AI tech for modelling skin conditions There are two currently problem with skincare consumers: first, they often lack understanding of their skin conditions and buy skincare prod... |
| 04.08.2023 | Latvian startup scene overview: July 2023 | Another month, another overview of developments in the local startup landscape. While summer is typically quieter regarding big announcements and news, it’s not the case this year. Latvian startups keep bringing amazing stories for us to co... |
| 21.07.2023 | LongeVC invests in SiPhox Health to scale access to healthcare | LongeVC is proud to participate in SiPhox Health’s $17 million Series A round to scale access to healthcare. SiPhox Health offers a low-cost and convenient health testing option with in-home sensors and mail-in kits. The test takes only ten... |
| 14.10.2022 | LongeVC invests to support battle against cancer | PreComb Therapeutics has closed its 1.3m CHF Pre-Series A Round. Biotech-focused venture capital firm, the Latvia-based LongeVC was among the investors, as were Vienna-based Kinled, family offices and private investors. PreComb is developin... |
| 07.10.2022 | Longevity for VCs: understanding the growing sector shaping the future of our lifespans | At LongeVC, we often receive the very straightforward question: what is longevity investing, and how can a VC categorize it? This is a great question. The answer differs a lot depending on investment ideologies and approaches, proving that ... |
| 04.10.2022 | CHF1.3 million to bring precision medicine to all cancer patients | |
| 19.05.2022 | Can We Fix Ovarian Aging? Here Is One Startup Up For The Task! | Concept of a healthy female reproductive system. getty |
| 30.06.2021 | Latvian startup Longenesis closes $1.2 million seed round | Longenesis announces its late seed round backed by a group of business angels led by Rustam Gilfanov, for a total of $1.2 million. The round was also joined by Ilya Suharenko, a private investor and one of the Managing Partners of LongeVC, ... |